Field Trip Health (FTRP) Stock Price, News & Analysis

Company Overview

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $1.12 to $1.12
• 50-Day Range: $0.84 to $5.75
• 52-Week Range: $0.71 to $6.41
• Volume: N/A
• Average Volume: 214,681 shs
• Market Capitalization: $65.20 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FTRP Stock Analysis - Frequently Asked Questions

How were Field Trip Health's earnings last quarter?

Field Trip Health Ltd. (NASDAQ:FTRP) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.75) by $0.15. The firm had revenue of $0.72 million for the quarter, compared to analyst estimates of $1.10 million. Field Trip Health had a negative trailing twelve-month return on equity of 62.71% and a negative net margin of 1,125.12%.

When did Field Trip Health's stock split?

Field Trip Health shares reverse split before market open on Wednesday, August 17th 2022. The 1-5 reverse split was announced on Wednesday, August 17th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What other stocks do shareholders of Field Trip Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Field Trip Health investors own include Mind Medicine (MindMed) (MNMD), HubSpot (HUBS), 3D Systems (DDD), ForgeRock (FORG), Netflix (NFLX) and Atai Life Sciences (ATAI).

Company Calendar

• Last Earnings: 11/15/2021
• Today: 4/26/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:FTRP
• CIK: 1865482
• Web: www.fieldtriphealth.com
• Phone: 833 222 0084
• Fax: 1-855-933-1211
• Employees: 104
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.77)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-43,630,000.00
• Net Margins: -1,125.12%
• Pretax Margin: -1,125.43%
• Return on Equity: -62.71%
• Return on Assets: -47.29%

Debt

• Debt-to-Equity Ratio: 0.40
• Current Ratio: 8.20
• Quick Ratio: 8.20

Sales & Book Value

• Annual Sales: $3.88 million
• Price / Sales: 16.80
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.92 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 58,215,000
• Free Float: N/A
• Market Cap: $65.20 million
• Optionable: Not Optionable
• Beta: N/A